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Multidrug resistance was defined as being intermediate or resistant
to at least 3 of these 6 drugs: amikacin, gentamicin, ciprofloxacin,
piperacillin, ceftazidime, and imipenem.
Results: Forty-eight episodes of bloodstream infections were iden-
tified in 30 patients (5 women; mean age 28.5 years). Gram-
negative isolates were Pseudomonas aeruginosa in 12 (25%), En-
terobacter cloacae in 4 (8.3%), Escherichia coli in 2 (4.2%), and
Acinetobacter spp in 2 (4.2%) of the episodes. There were more
primary bloodstream infections in the control group, whereas sec-
ondary bloodstream infections from wound infections were more
common in patients in the multidrug-resistant group. Regarding
prior antibiotic use, aminoglycoside use was significantly higher in
patients in the multidrug-resistant group (p<0.001). See Table 1.
Conclusion: Multidrug-resistant strains of bacteria are being in-
creasingly reported. In these cases, the choice of therapy often
becomes limited. Several factors suggest that the emergence and
spread of multidrug-resistant non-fermenting bacteria is related to
the overuse of antimicrobial agents, although the degree of risk ap-
pears to differ with different agents. A strong association between
use and resistance has been documented for carbapenems. In this
study, previous use of aminoglycosides was found to be statistically
significant for MDR strains.
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Introduction: Colistin was re-introduced into clinical practice dur-
ing the last years for the treatment of nosocomial infections caused
by multidrug-resistant Gram-negative bacteria. The aim of this
study is to evaluate the efficacy and side effects of colistin in the
burn infections caused by pan-resistant Pseudomonas aeruginosa
strains.
Materials and Methods: Medical records of seven burn patients
who received colistin were evaluated retrospectively. Underlying
diseases, site of infection, antibacterial susceptibility pattern of
the causative agent, clinical progress, laboratory findings espe-
cially renal function tests, dose of colistin and side effects of col-
istin were the data collected. Deterioration of renal function was
defined as an increase of more than 50% of the baseline to a value
higher than 1.3mg/dL or as a need for renal replacement therapy.
Results: All seven burn patients had burn wounds infected with
pan-resistant P. aeruginosa and two of these also had bacteremia.
Two burn patients died during colistin treatment; one was due to
other causes except infection (extensive burn), and the other had
febrile disease probably associated with P. aeruginosa. Adult pa-
tients who had normal renal function tests received a dose range
of 1-3 million units q8h. Patients received colistin for 4 to 21 days.
Cultures from the infected sites became sterile in the range of 2
days-13 days. Neurotoxicity, nephrotoxicity, skin rash or gastroin-
testinal disturbances was not observed in any of these patients.
Conclusion: Limited data obtained from seven patients show that
intravenous colistin constitutes a relatively safe and effective ther-
apeutic intervention in cases of severe burn infections caused by
multidrug-resistant Gram-negative bacteria.
96
Fungal Infections in Burn Patients
Özlem Azap1, Hande Arslan1, Funda Timurkaynak1, Sezen Özkök1,
Özgür Bas¸aran2, Mehmet Haberal2. 1Department of Infectious
Disease, Baskent University, Ankara, Turkey; 2General Surgery,
Baskent University, Ankara, Turkey
Introduction: Fungal infections particularly bloodstream infections
due to Candida spp. cause high morbidity and mortality in health-
care settings. Burn patients are vulnerable to fungal infections be-
cause they generally receive broad spectrum antibacterial therapy
and total parenteral nutrition.
Objective: The objective of this study is to determine the inci-
dence of fungal infections in burn patients.
Materials and Methods: Medical records of 290 burn patients hos-
pitalized between the years 2003 and 2007 at Baskent University
Burn Unit were evaluated retrospectively. Infections were defined
according to the criteria described in Taneja' s article. Two hun-
dred and ninety burn patients were followed during the five-year
period; the ages of the patients were within the range of 2 months
and 90 years and 88 (30%) were female.
Results: Twenty-five fungal infection episodes caused by Candida
spp. were diagnosed in 20 patients during the five-year period.
Fourteen of these episodes were bloodstream infections, six were
urinary tract infections and five were burn wound infections. Nine
of the fourteen (64%) candidemia episodes were due to Candida
albicans and the remaining five (36%) were due to non-albicans
Candida spp.
Conclusion: Management of fungal infections in burn patients
should deserve more attention because of high mortality rates.
Appropriate antifungal therapy is of great importance. One third
of fungal causes of bloodstream infections in this study are non-
albicans Candida strains. The various antifungal susceptibility pro-
files of non-albicans Candida strains mandates the documentation
of antifungal susceptibility results.
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Background: We have previously shown that 30-40% of surgical
patients with recurrent gastrointestinal perforation/anastomotic
leakage, or acute necrotizing pancreatitis develop intraabdominal
candidiasis (IC) (Lancet 1989, 2:1437). These patients benefit of
fluconazole prophylaxis (Px) (Crit Care Med 1999, 27:1066). A cor-
rected Candida colonization index (CCI) ≥0.4 is a major risk factor
for IC (Ann Surg 1994, 220:751). CSP, a new therapy for IC including
azole-resistant Candida spp., may be used for Px of IC.
Objective: To conduct a non-comparative pilot study on the effi-
cacy and safety of caspofungin (CSP) for Px of IC in high-risk surgi-
cal patients.
Methods: Inclusion criteria: age >18, surgery for recurrent gas-
trointestinal perforations/anastomotic leakage or acute pancreati-
tis. Exclusion criteria: documented IC, fluconazole Px. CSP Px (70
mg, then 50 mg/day) was given until resolution of the surgical con-
dition. Candida colonization was monitored 1x weekly at ≥3 sites
and the CCI calculated. Success was defined by the absence of IC
during CSP Px. Occurrence of CSP-related SAE was recorded.
Results: Nineteen patients were enrolled: 16/3 males/females,
median age 69 (range 40-84). Underlying surgical conditions were:
recurrent gastrointestinal perforation/anastomotic leakage (n),
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acute pancreatitis (n=3). At study entry, 14 (74%) patients were
in the ICU (median Simplified Acute Physiology Score II 45, range
31-65), 19 (100%) received antibacterial therapy and 17 (89%) were
colonized with Candida (C. albicans in 69%; CCI ≥0.4 in 1/17 case,
5%). Median duration of CSP Px was 16 days (range 4-46). During
CSP Px, 17 (89%) patients remained colonized (C. albicans in 68%),
but 0/17 developed a CCI ≥0.4. CSP was successful for prevention
of IC in 18 (95%) patients. Among 5 deaths, none was attributed
to IC. No severe CSP-related SAE requiring discontinuation of Px
occurred.
Discussion: The results of this pilot study suggest that caspofungin
is efficacious and safe for prophylaxis of intra-abdominal candidia-
sis in high-risk surgical patients.
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Objectives: The aim of this study was to evaluate the incidence of
microbial pathogens isolated from cultures of venous catheter tips
(VCT) and determine their susceptibility patterns to antimicrobial
agents from patients hospitalized in the intensive care unit (ICU).
Methods: During a four year period (2003-2007) 925 VCT were cul-
tured from patients hospitalized in the ICU of our hospital. Patients
between 18-60 years aged and were hospitalized for more than 48
hours. Specimens were cultured and evaluated according to the
semi-quantitative method (MAKI' S) for aerobic microorganisms and
fungi. Antibiotic susceptibility testing was performed by the agar
disk diffusion method according to CLSI guidelines.
Results: From 925 VCT cultures 158 (17%) were positive. Of them
23% grew Acinetobacter baumanii, 22% Pseudomonas aeruginosa,
26% Enterobacteriaceae, 6% Enterococcus spp., 3% Staphylococcus
aureus, 16% Staphylococcus coagulase-negative and 3% Candida
spp. 74% of A. baumanii and Ps. aeruginosa strains were resistant
to Carbapanems, 69% to Gentamycin and 81% to Amikacin.
Twenty-six percent of Enterobacteriaceae strains were resistant to
Carbapenems, 24% to Gentamycin and 48% to Amikacin. From S. au-
reus and Staphylococcus coagulase-negative isolated strains 60%
and 66% respectively were resistant to Methicilin. 22% of Entero-
coccus spp. were resistant to Vancomycin and Teicoplanin (van A).
Conclusions: A. baumanii and Ps. aeruginosa were the most
common isolated pathogens followed by Staphylococci coagulase-
negative. An elevated percentage of multiresistant strains was ob-
served. The knowledge of the resident microbial flora and their
antimicrobial susceptibility profiles is necessary in order to formu-
late a rational policy in patients with catheter devices.
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Background: Enterococci may not be the main pathogens associ-
ated with Intensive Care Unit (ICU) patients infections but their
increasing resistance rates to many commonly administrated an-
tibiotics often leads to the need of using a combination of an-
timicrobial agents when dealing with these infections. Even though
aminoglycosides used alone have very low efficiency against these
microorganisms, their combination with an antibiotic that targets
bacterial cell wall has proved to be successful. Testing for high
level aminoglycoside resistance (HLAR) is a laboratory means of
evaluating the efficiency of such a combination.
Objectives: To assess antimicrobial susceptibility rates and HLAR
of Enterococcus strains isolated from ICU patients during one year
period of time.
Methods: Between 01-01-2007 and 31-12-2007, 50 Enterococcus
strains were isolated from different ICU patients' samples (mainly
bronchial aspirates, urine, blood and wounds). Identification of
bacteria was made by standard laboratory proceedings and suscep-
tibility testing to antimicrobial agents was performed with the disk
diffusion test (Kirby-Bauer method) along with the miniAPI system.
HLAR test was performed with the disk diffusion test according to
the CLSI guidelines with the use of 120 microgram Gentamicin and
300 microgram Streptomycin disks.
Results: Enterococcus faecium was the most frequent enterococ-
cal isolate (40%), followed by Ent. faecalis (32%), Ent. casseliflavus
(12%), Ent. gallinarum (12%) and Ent. durans (4%). All strains
were susceptible to vancomycin and teicoplanin while susceptibil-
ity rates for quinupristin-dalfopristin were for Ent. faecium 40%,
Ent. faecalis 0%, Ent. casseliflavus 0%, Ent. gallinarum 66.6% and
Ent. durans 0%. HLAR is shown in the following table.
Gentamicin 120µg Streptomycin 300µg
(R %) (R %)
Ent. faecium 60 90
Ent. faecalis 50 50
Ent. casseliflavus 33.3 33.3
Ent. gallinarum 0 33.3
Ent. durans 100 100
Conclusions: Glycopeptides remain highly efficient while strep-
togramins showed lower efficiency. Enterococci species isolated
from ICU patients had high HLAR rates especially in the case of
Ent. faecium, Ent. faecalis and Ent. durans. Since high level resis-
tance to aminoglycosides means that these antibiotics will not be
synergistic with cell-wall-active agents, testing for HLAR is impor-
tant for the proper therapeutical approach of these patients.
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Background: Gram-negative bacteria are the main pathogens asso-
ciated with Intensive Care Unit (ICU) patients infections and their
increasing resistance rates to multiple antimicrobial agents con-
tribute to high morbidity and mortality rates.
Objectives: To assess susceptibility rates to carbapenems and
aminoglycosides of the most frequently isolated Gram-negative
bacteria from ICU clinical specimens.
Methods: During one year period of time (1/1/2007 till
31/12/2007) 409 Gram-negative bacterial strains were recovered
from different samples obtained from ICU patients (including
bronchial aspirates, urine, central venous catheters, blood and
